Composition for inhibiting osteoclasts containing agastache rugosa extract as active ingredient, and use thereof
US-12472221-B2 · Nov 18, 2025 · US
Korea Inst Oriental Medicine patents
Korea Inst Oriental Medicine holds 95 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 95 |
| Recent patents | 15 |
| First publication | Mar 26, 2015 |
| Latest publication | Nov 18, 2025 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Composition for improving memory and preventing, alleviating, or treating cognitive disorder comprising yukgunjatang as effective component
US-2025121020-A1 · Apr 17, 2025 · US
Composition for treating alzheimer's disease including mixed extract of pinellia tuber, zizyphi fructus, glycyrrhiza radix, ginseng radix, zingiberis rhizoma, scutellariae radix, and coptidis rhizoma as active ingredient
US-2025064879-A1 · Feb 27, 2025 · US
Use of aristoloxazine c having anticancer activity
US-2025059203-A1 · Feb 20, 2025 · US
Composition for preventing, ameliorating or treating respiratory disease comprising lysimachia mauritiana extract as effective component
US-2025049873-A1 · Feb 13, 2025 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Composition for inhibiting osteoclasts containing agastache rugosa extract as active ingredient, and use thereof
US-12472221-B2 · Nov 18, 2025 · US
Composition for improving memory and preventing, alleviating, or treating cognitive disorder comprising yukgunjatang as effective component
US-2025121020-A1 · Apr 17, 2025 · US
Composition for treating alzheimer's disease including mixed extract of pinellia tuber, zizyphi fructus, glycyrrhiza radix, ginseng radix, zingiberis rhizoma, scutellariae radix, and coptidis rhizoma as active ingredient
US-2025064879-A1 · Feb 27, 2025 · US
Use of aristoloxazine c having anticancer activity
US-2025059203-A1 · Feb 20, 2025 · US
Composition for preventing, ameliorating or treating respiratory disease comprising lysimachia mauritiana extract as effective component
US-2025049873-A1 · Feb 13, 2025 · US
Top CPC classifications
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A23L33/105 | 48 |
| A23V2002/00 | 41 |
| A61K2236/331 | 25 |
| A61K2236/333 | 17 |
| A61K2300/00 | 15 |
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 87 |
| Physics | 16 |
| Chemistry & Metallurgy | 5 |
| Operations & Transport | 3 |
| Electricity | 2 |
| Cross-Sectional Technologies | 2 |
Frequently asked questions
Answers are generated from the same data shown on this page.
- How many patents does Korea Inst Oriental Medicine have in patentsdb?
- Korea Inst Oriental Medicine is linked to 95 publications as assignee in our database.
- What technology areas does Korea Inst Oriental Medicine patent most?
- Top mapped technology areas by patent count: Human Necessities (87); Physics (16); Chemistry & Metallurgy (5).
- Is Korea Inst Oriental Medicine's patent activity growing?
- In our data, assignee counts were 7 in 2024 and 7 in 2025 (similar year over year).
- What are recent patents assigned to Korea Inst Oriental Medicine?
- See the “Recent patents” section above for the latest 5 publications we attribute to this assignee.